Free Trial

Biotricity (BTCY) Competitors

Biotricity logo
$0.50 -0.14 (-21.88%)
As of 03:59 PM Eastern

BTCY vs. APT, ZYXI, ECOR, RBOT, PETV, MODD, MLSS, DRIO, POCI, and STRR

Should you be buying Biotricity stock or one of its competitors? The main competitors of Biotricity include Alpha Pro Tech (APT), Zynex (ZYXI), electroCore (ECOR), Vicarious Surgical (RBOT), PetVivo (PETV), Modular Medical (MODD), Milestone Scientific (MLSS), DarioHealth (DRIO), Precision Optics (POCI), and Star Equity (STRR). These companies are all part of the "medical equipment" industry.

Biotricity vs. Its Competitors

Alpha Pro Tech (NYSE:APT) and Biotricity (NASDAQ:BTCY) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Pro Tech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Biotricity
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Biotricity had 1 more articles in the media than Alpha Pro Tech. MarketBeat recorded 1 mentions for Biotricity and 0 mentions for Alpha Pro Tech. Alpha Pro Tech's average media sentiment score of 0.00 equaled Biotricity'saverage media sentiment score.

Company Overall Sentiment
Alpha Pro Tech Neutral
Biotricity Neutral

Alpha Pro Tech has a net margin of 6.99% compared to Biotricity's net margin of -80.42%. Alpha Pro Tech's return on equity of 6.70% beat Biotricity's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Pro Tech6.99% 6.70% 5.76%
Biotricity -80.42%N/A -188.47%

Alpha Pro Tech has higher revenue and earnings than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Pro Tech$58.56M0.82$4.19M$0.3413.53
Biotricity$12.06M1.11-$14.09M-$0.21-2.38

22.7% of Alpha Pro Tech shares are owned by institutional investors. Comparatively, 3.9% of Biotricity shares are owned by institutional investors. 15.0% of Alpha Pro Tech shares are owned by company insiders. Comparatively, 10.1% of Biotricity shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Alpha Pro Tech has a beta of 0.45, indicating that its share price is 55% less volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500.

Summary

Alpha Pro Tech beats Biotricity on 9 of the 13 factors compared between the two stocks.

Get Biotricity News Delivered to You Automatically

Sign up to receive the latest news and ratings for BTCY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BTCY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BTCY vs. The Competition

MetricBiotricitySurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$13.36M$70.83M$6.17B$10.68B
Dividend YieldN/AN/A5.70%4.84%
P/E Ratio-0.4610.2429.4727.36
Price / Sales1.1132.36589.24132.03
Price / CashN/A18.4125.8230.35
Price / Book-0.3816.5012.526.69
Net Income-$14.09M-$27.29M$3.32B$276.59M
7 Day Performance-18.30%-3.18%2.43%0.97%
1 Month Performance-20.63%0.13%8.78%3.95%
1 Year Performance85.19%37.59%62.11%36.40%

Biotricity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BTCY
Biotricity
N/A$0.50
-21.9%
N/A+137.0%$13.36M$12.06M-0.4640Gap Down
High Trading Volume
APT
Alpha Pro Tech
N/A$4.81
+0.7%
N/A-22.2%$50.32M$58.56M12.99120
ZYXI
Zynex
2.6288 of 5 stars
$1.48
+1.7%
$4.90
+232.2%
-83.4%$44.69M$192.35M-1.57770
ECOR
electroCore
2.2898 of 5 stars
$5.10
+3.1%
$25.50
+399.9%
-38.9%$41.12M$25.18M-3.1750
RBOT
Vicarious Surgical
1.758 of 5 stars
$6.68
+2.2%
$7.00
+4.9%
-24.2%$39.95MN/A-0.67210Gap Up
High Trading Volume
PETV
PetVivo
N/A$1.30
flat
N/A+150.1%$38.07M$1.05M-2.8920
MODD
Modular Medical
1.1388 of 5 stars
$0.67
+0.0%
N/A-73.9%$37.04MN/A-1.3120Short Interest ↓
Gap Up
MLSS
Milestone Scientific
2.0597 of 5 stars
$0.46
+1.6%
$1.25
+172.3%
-48.2%$36.06M$9.08M-6.5630Short Interest ↑
Gap Up
DRIO
DarioHealth
1.9422 of 5 stars
$14.60
-6.1%
$40.00
+174.0%
-36.7%$33.64M$27.04M-1.12200Gap Up
POCI
Precision Optics
0.2508 of 5 stars
$4.33
+3.0%
N/A-1.2%$33.35M$19.09M-5.1580
STRR
Star Equity
1.1445 of 5 stars
$11.44
-2.2%
$5.00
-56.3%
+171.6%$31.57M$140.06M-8.801,300

Related Companies and Tools


This page (NASDAQ:BTCY) was last updated on 10/20/2025 by MarketBeat.com Staff
From Our Partners